Project Grant K12TR006152
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $553,631 on July 6, 2026, under the CTSA Predoctoral T32 program (CFDA 93.350) to support predoctoral trainee development in clinical and translational science. The award funds a predoctoral training program that will support 10 trainees at any given time, recruited from PhD, MD, DMD, and VMD doctoral programs, with individual appointments lasting 1–3 years depending on career stage. The training plan...
- The National Center for Advancing Translational Sciences awarded a $10.805 million Cooperative Agreement to the University of Pennsylvania on July 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). The Penn-CHOP Clinical and Translational Science Award (CTSA) Hub will advance clinical and translational science through four integrated aims: developing and disseminating novel approaches to translational therapeutics; applying data science resources and...
- The National Center for Advancing Translational Sciences awarded Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) $725,350 on August 13, 2026, under the NCATS K12 Program (CFDA 93.350) to support early-career faculty development in translational science. The award funds a structured 2–3 year intensive career development and research training program for 3 cohorts of early-career faculty scholars (3 scholars per cohort), organized around three pillars:...
- The National Center for Advancing Translational Sciences awarded a cooperative agreement totaling $7.892 million to Pennsylvania State University (operating as Penn State Milton S. Hershey Medical Center) on August 6, 2026, under CFDA 93.350. The award funds the Penn State Clinical and Translational Science Institute (CTSI) to advance clinical and translational science through investigator-centered research infrastructure, development and dissemination of innovations, expansion of Pennsylvania's...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $1,025,770 on August 1, 2026, under the NCATS K12 Program (CFDA 93.350) to develop the next generation of clinical and translational research experts and translational scientists. The University of Pittsburgh will train scholars in translational science and domain-specific skills required for careers as clinical and translational researchers and translational scientists, provide cross-disciplinary...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $558,631 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to develop and deliver predoctoral training in clinical and translational research and translational science. The University of Pittsburgh's Institute for Clinical Research Education (ICRE), in collaboration with the Clinical and Translational Science Institute (CTSI), will train the next...
- The National Center for Advancing Translational Sciences awarded University of Massachusetts Medical School $949,994 on April 1, 2026, under the NCATS program (CFDA 93.350) to support a K12 career development program in translational science. The award funds the development and mentorship of junior faculty scholars pursuing careers in translational science. The program will support four NCATS-funded scholars at any given time, forming the core of a nine-scholar umbrella initiative that...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $502,465 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral T32 training initiative in clinical and translational research. The award funds the University of Pittsburgh Institute for Clinical Research Education (ICRE) to deliver comprehensive postdoctoral fellowship training and career development programs designed to equip...
- The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $3.312 million on August 10, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to develop and test infrastructure for parent-child behavioral interventions addressing obesity in families. The project, titled "Research Redesign to Reduce Chronic Conditions in Families," combines the adult-focused resources of the University of Pennsylvania with the...
The National Center for Advancing Translational Sciences awarded the University of Pennsylvania $1.62 million on August 1, 2026, under the NCATS program (CFDA 93.350) to operate a mentored research career development program in clinical and translational science. The University of Pennsylvania will identify, recruit, train, and retain nine early-career scientists across varied educational backgrounds and professional experiences, guiding them toward scientific independence and leadership in clinical and translational research. The program supports scholar appointments of 2–3 years for physicians, dentists, veterinarians, and doctoral-level biomedical scientists. Training combines structured mentorship, scientific skill development in clinical and translational science, sponsorship, and professional development guided by individual development plans, situated within the university's integrated research ecosystem. The program aims to equip scholars with specialized clinical and translational science expertise, enhance professional development and leadership capabilities, and launch scholars toward independent research careers. The University of Pennsylvania operates this program in partnership with the Children's Hospital of Philadelphia, building on a 20-year history of training clinical and translational scientists through the CTSA Hub. The award covers the period of performance through May 30, 2031, with place of performance in Philadelphia, Pennsylvania.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $1.6m | 7/24/26 |